Výsledky vyhledávání - "Mogammad Hamid"

Selective therapeutic benefit of X-rays and inhibitors of EGFR, PI3K/mTOR, and Bcl-2 in breast, lung, and cervical cancer cells

Autor: John M. Akudugu, Mogammad Hamid, Antonio Serafin

Publikováno v: European journal of pharmacology. 912

Cancer continues to be a growing burden, especially in the resource limited regions of the world, and more effective and affordable therapies are highly desirable. In this study, the effect of X-ray irradiation and four inhibitors, viz. those against

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b6b65a166f9fd7b663d951293700889
https://pubmed.ncbi.nlm.nih.gov/34736967

Zobrazit plný text záznamu

Combined Inhibition of PI3K, mTOR and Bcl-2 Significantly Radiosensitises Progesterone and Oestrogen Receptor Negative Breast Cancer Cells

Autor: John M. Akudugu, Roswita Hamunyela, Mogammad Hamid, Antonio Serafin

Publikováno v: Journal of Cancer Biology and Therapeutics. 2

Patients with triple-negative breast cancers (TNBC) constitute about one-fifth of all breast cancer patients. TNBC is an aggressive and heterogeneous disease entity in comparison with other types of breast cancer and, therefore, tends to be resistant

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bfe62507e191f8b62ed92aae60044d0f
https://doi.org/10.18314/gjct.v2i1.138

Zobrazit plný text záznamu

Inhibition of PI3K and mTOR Sensitises Oestrogen Receptor Positive Human Breast Cancer Cells to a Large Fraction of Radiation Dose

Autor: Mogammad Hamid, John Akudugu, Roswita Hamunyela, Antonio Serafin

Publikováno v: Journal of Cancer Biology and Therapeutics. 2

Resistance to radiotherapy has been attributed to the expression of proteins pertinent to cancer cell survival. Treatment approaches that can effectively target these proteins, to possibly augment the effect of radiotherapy, are lacking. This is part

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66141846e7e7746a196f84bf15b21b19
https://doi.org/10.18314/gjct.v2i1.74

Zobrazit plný text záznamu

NVP-BEZ235 Enhances Radiosensitivity of Human Prostate Cancer Cells but Acts as a Radioprotector to Normal Prostate Cells

Autor: John M. Akudugu, Mogammad Hamid, Antonio Serafin, Maleka S, Roswita Hamunyela, Daniel Achel

Publikováno v: Journal of Cancer Biology and Therapeutics. 1

Targeted therapy for prostate cancer may offer potential improvement over current conventional therapiesÃ‚Â because of its specificity. Although conventional treatments are effective, they are not always curative, andhave several limitations. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::07a56339ccedc5c842cffa2b9b1401cd
https://doi.org/10.18314/gjct.v1i1.32

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání